Phosphorylation Sites of the Gastric Inhibitory Polypeptide Receptor (GIPR) Revealed by Trapped-Ion-Mobility Spectrometry Coupled to Time-of-Flight Mass Spectrometry (TIMS-TOF MS)
Journal of the American Chemical Society · 27.12.2023 · 145 (51) · 28030-28037
DOI: 10.1021/jacs.3c09078 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 13.12.2023. Verfasst von Kyle A Brown und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin 53706, United States. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS, NIH HHS.
Themen: Mobilisation
Abstract (Originalsprache)
The gastric inhibitory polypeptide receptor (GIPR), a G protein-coupled receptor (GPCR) that regulates glucose metabolism and insulin secretion, is a target for the development of therapeutic agents to address type 2 diabetes and obesity. Signal transduction processes mediated by GPCR activation typically result in receptor phosphorylation, but very little is known about GIPR phosphorylation. Mass spectrometry (MS) is a powerful tool for detecting phosphorylation and other post-translational modifications of proteins and for identifying modification sites. However, applying MS methods to GPCRs is challenging because the native expression levels are low and the hydrophobicity of these proteins complicates isolation and enrichment. Here we use a widely available technique, trapped-ion-mobility spectrometry coupled to time-of-flight mass spectrometry (TIMS-TOF MS), to characterize the phosphorylation status of the GIPR. We identified eight serine residues that are phosphorylated, one in an intracellular loop and the remainder in the C-terminal domain. Stimulation with the native agonist GIP enhanced phosphorylation at four of these sites. For comparison, we evaluated tirzepatide (TZP), a dual agonist of the glucagon-like peptide-1 (GLP-1) receptor and the GIPR that has recently been approved for the treatment of type 2 diabetes. Stimulation with TZP enhanced phosphorylation at the same four sites that were enhanced with GIP; however, TZP also enhanced phosphorylation at a fifth site that is unique to this synthetic agonist. This work establishes an important and accessible tool for the characterization of signal transduction via the GIPR and reveals an unanticipated functional difference between GIP and TZP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin 53706, United States.
- Department of Cell and Regenerative Biology, University of Wisconsin-Madison, Madison, Wisconsin 53705, United States.
- Human Proteomics Program, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin 53705, United States.
ORCID-Profile: Kyle A Brown, Rylie K Morris, Ying Ge, Samuel H Gellman
Förderung
- NHLBI NIH HHS
- NIGMS NIH HHS
- NIH HHS
- William F. Vilas Trust Estate
- National Institutes of Health
Zitieren
APA
Brown, K. A., Morris, R. K., Eckhardt, S. J., Ge, Y., & Gellman, S. H. (2023). Phosphorylation Sites of the Gastric Inhibitory Polypeptide Receptor (GIPR) Revealed by Trapped-Ion-Mobility Spectrometry Coupled to Time-of-Flight Mass Spectrometry (TIMS-TOF MS). Journal of the American Chemical Society, 145(51), 28030-28037. https://doi.org/10.1021/jacs.3c09078
Vancouver
Brown KA, Morris RK, Eckhardt SJ, Ge Y, Gellman SH. Phosphorylation Sites of the Gastric Inhibitory Polypeptide Receptor (GIPR) Revealed by Trapped-Ion-Mobility Spectrometry Coupled to Time-of-Flight Mass Spectrometry (TIMS-TOF MS). Journal of the American Chemical Society. 2023;145(51):28030-28037. doi:10.1021/jacs.3c09078
BibTeX
@article{Brown2023,
author = {Brown, Kyle A and Morris, Rylie K and Eckhardt, Samantha J and Ge, Ying and Gellman, Samuel H},
title = {Phosphorylation Sites of the Gastric Inhibitory Polypeptide Receptor (GIPR) Revealed by Trapped-Ion-Mobility Spectrometry Coupled to Time-of-Flight Mass Spectrometry (TIMS-TOF MS)},
journal = {Journal of the American Chemical Society},
year = {2023},
volume = {145},
number = {51},
pages = {28030--28037},
doi = {10.1021/jacs.3c09078}
}
EUVIMED